Bellevue Group AG Has $31.41 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Bellevue Group AG lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 6.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 325,776 shares of the biotechnology company’s stock after selling 24,112 shares during the quarter. Bellevue Group AG owned approximately 0.17% of […]

Related Keywords

George Eric Davis ,Brian Mueller ,Biomarin Pharmaceutical Inc ,Morningstar Investment Services ,Avoro Capital Advisors ,Cibc World Markets Corp ,Wells Fargo Company ,Cantor Fitzgerald ,Securities Exchange Commission ,Nasdaq ,Bellevue Group ,Scotiabank ,Lighthouse Investment Partners ,Morgan Stanley ,Biomarin Pharmaceutical ,Free Report ,Capital Advisors ,Investment Partners ,Investment Services ,Exchange Commission ,Eric Davis ,Wells Fargo ,Marin Pharmaceutical ,Get Free Report ,Marin Pharmaceutical Inc ,Visit Holdingschannel ,Biomarin Pharmaceutical Daily ,